GLOBAL
Global Medical Devices 25 Dividend Yield
The LAPIS Global Medical Devices 25 Dividend Yield Analysis is composed of 25 worldwide best-known and leading medical device companies. All companies in our equally weighted equity analysis have a market capitalisation greater than USD 5 billion and 80% of them have paid uninterrupted dividends over the last 5 years. Hence, a maximum of 20% of the companies included in our unique equity analysis do not apply a strict dividend payment policy or have paid their regular dividends for less than 5 years.
Deloitte analysis facts
Dedicated LAPIS Analyses designed around Deloitte compliance requirements.
Asset class
EquityRegion
GLOBAL